Answer:
The potential risks associated with plant-based pharmaceuticals include: pollen transfer to related species, contamination of non-transgenic crops intended for the consumption by humans, allergic reactions to the drugs produced from the genetically engineered plant, and persistence of genetically engineered material to persist in the environment and accumulate in non-target organisms. Risk assessment of plant-made pharmaceuticals should be reviewed on a case-by-case basis because the plants used to produce proteins each have different risks associated with them.
<span>Streptococcus is a genus of coccus (spherical) Gram-positive bacteria belonging to the phylum Firmicutes[3] and the order Lactobacillales (lactic acid bacteria). Cell division in this genus occurs along a single axis in these bacteria, thus they grow in chains or pairs, hence the name—from Greekstreptos, meaning easily bent or twisted, like a chain (twisted chain). Contrast this with staphylococci, which divide along multiple axes and generate grape-like clusters of cells.)</span>
Scientists
can also glimpse the awful effects of Alzheimer's disease when they look at
brain tissue beneath the microscope:
Alzheimer's tissue has numerous fewer nerve
cells and synapses than a well brain.
<span>
<span>Plaques, unusual
clusters of protein particle, which are construct up between nerve cells.</span>
</span>
<span>
<span><span>Dead and dying nerve cells contain tangles,</span> which
are produce of twisted strands of a further protein.</span>
</span>
<span>Scientists
are not absolutely sure what causes cell death and tissue deficiency in the
Alzheimer's brain, but plaques and tangles are key suspects.</span>
